Merging CHEMISTRY AND BIOLOGY TO BENEFIT THE LIVES OF PATIENTS
Dr. Hui Li
Dr. Hui Li is the President and CEO of Adcentrx Therapeutics with over 20 years of drug discovery and business development experience in the biotech and pharmaceutical industry.
Dr. Pia Challita-Eid
Dr. Pia Challita-Eid serves as the Head of Research at Adcentrx Therapeutics. She brings over 20 years of experience in the biotechnology industry, contributing to the discovery and progression into the clinic of over 12 drug candidates including the FDA-approved product Padcev™.
Dr. Alexander Chu-Kung
Alexander Chu-Kung is the head of development at Adcentrx Therapeutics. Prior to joining Adcentrx, Dr Chu-Kung was the Senior Director of Development at Levena Biopharma, a subsidiary of Sorrento Therapeutics where he was responsible for all aspects of process development, cGMP manufacturing and clinical supply of the antibody drug conjugate pipeline.